| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2022 | A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants | Lee, I-Jung; Sun, Cheng-Pu ; Wu, Ping-Yi; Lan, Yu-Hua; Wang, I-Hsuan ; Liu, Wen-Chun ; Yuan, Joyce, Pei-Yi; Chang, Yu-Wei; Tseng, Sheng-Che; Tsung, Szu-I; Chou, Yu-Chi ; Kumari, Monika; Lin, Yin-Shiou; Chen, Hui-Feng; Chen, Tsung-Yen; Lin, Chih-Chao; Chiu, Chi-Wen; Hsieh, Chung-Hsuan; Chuang, Cheng-Ying; Cheng, Chao-Min; Lin, Hsiu-Ting; Chen, Wan-Yu; Hsu, Fu-Fei; Hong, Ming-Hsiang; Liao, Chun-Che ; Chang, Chih-Shin; Liang, Jian-Jong; Ma, Hsiu-Hua; Chiang, Ming-Tsai; Liao, Hsin-Ni; Ko, Hui-Ying; Chen, Liang-Yu; Ko, Yi-An; Yu, Pei-Yu; Yang, Tzu-Jing; Chiang, Po-Cheng; Hsu, Shang-Te ; Lin, Yi-Ling ; Lee, Chong-Chou; Wu, Han-Chung ; Tao, Mi-Hua | Journal of Biomedical Science 29(1), 49 | | | |
| 2022 | A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants | Chang Yi Wang; Kao-Pin Hwang; Hui-Kai Kuo; Wen-Jiun Peng; Yea-Huei Shen; Be-Sheng Kuo; Juin-Hua Huang; Hope Liu; Yu-Hsin Ho; Feng Lin; Shuang Ding; Zhi Liu; Huan-Ting Wu; Ching-Tai Huang; Yuarn-Jang Lee; Ming-Che Liu; Yi-Ching Yang; Po-Liang Lu; Hung-Chin Tsai; Chen-Hsiang Lee; Zhi-Yuan Shi; Chun-Eng Liu; Chun-Hsing Liao; Feng-Yee Chang; Hsiang-Cheng Chen; Fu-Der Wang; Kuo-Liang Hou; Jennifer Cheng; Min-Sheng Wang; Ya-Ting Yang; Han-Chen Chiu; Ming-Han Jiang; Hao-Yu Shih; Hsuan-Yu Shen; Po-Yen Chang; Yu-Rou Lan; Chi-Tian Chen; Yi-Ling Lin ; Jian-Jong Liang; Chun-Che Liao ; Yu-Chi Chou ; Mary Kate Morris; Carl V. Hanson; Farshad Guirakhoo; Michael Hellerstein; Hui-Jing Yu; Chwan-Chuen King; Tracy Kemp; D. Gray Heppner; Thomas P. Monath | Journal of Clinical Investigation 132(10), e157707 | | | |
| 2016 | A new animal model containing human SCARB2 and lacking stat-1 is highly susceptible to EV71 | Liou, AT; Wu, SY; Liao, CC ; Chang, YS; Chang, CS; Shih, C | Scientific Reports 6, 31151 | | | |
| 2022 | A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern | Lee, I-Jung; Lan, Yu-Hua; Wu, Ping-Yi; Wu, Yan-Wei; Chen, Yu-Hung; Tseng, Sheng-Che; Kuo, Tzu-Jiun; Sun, Cheng-Pu ; Jan, Jia-Tsrong ; Ma, Hsiu-Hua; Liao, Chun-Che ; Liang, Jian-Jong; Ko, Hui-Ying; Chang, Chih-Shin; Liu, Wen-Chun ; Ko, Yi-An; Chen, Yen-Hui ; Sie, Zong-Lin; Tsung, Szu-I; Lin, Yi-Ling ; Wang, I-Hsuan ; Tao, Mi-Hua | Emerging microbes & infections 12(1), 2149353 | | | |
| 2020 | A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study | Tsai, Keng-Chang; Huang, Yi-Chia; Liaw, Chia-Ching; Tsai, Chia-I; Chiou, Chun-Tang; Lin, Chien-Jung; Wei, Wen-Chi; Lin, Sunny, Jui-Shan; Tseng, Yu-Hwei; Yeh, Kuo-Ming; Lin, Yi-Ling ; Jan, Jia-Tsrong; Liang, Jian-Jong; Liao, Chun-Che ; Chiou, Wen-Fei; Kuo, Yao-Haur; Lee, Shen-Ming; Lee, Ming-Yung; Su, Yi-Chang | Biomedicine & Pharmacotherapy 133, 111037 | | | |
| 2021 | Correction to “Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir” | Chen, T; Fei, CY; Chen, YP; Sargsyan, K; Liang, JJ; Liao, CC ; Lin, YL ; Chang, CP; Yuan, HS ; Lim, C | ACS pharmacology & translational science 4(3), 1246 | | | |
| 2021 | Correction: Multi-targeting of functional cysteines in multiple conserved SARS-CoV-2 domains by clinically safe Zn-ejectors | Sargsyan, Karen; Lin, Chien-Chu; Chen, Ting; Grauffel, Cédric; Chen, Yi-Ping; Yang, Wei-Zen; Liang, Jian-Jong; Liao, Chun-Che ; Lin, Yi-Ling ; Yuan, Hanna S. ; Lim, Carmay | Chemical Science 12(17), 6210 | | | |
| 2021 | CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge | Lien, Chia-En; Lin, Yi-Jiun; Chen, Charles; Lian, Wei-Cheng; Kuo, Tsun-Yung; Campbell, John, D.; Traquina, Paula; Lin, Meei-Yun; Liu, Luke, Tzu-Chi; Chuang, Ya-Shan; Ko, Hui-Ying; Liao, Chun-Che ; Chen, Yen-Hui; Jan, Jia-Tsrong; Ma, Hsiu-Hua; Sun, Cheng-Pu ; Lin, Yin-Shiou; Wu, Ping-Yi; Wang, Yu-Chiuan; Tao, Mi-Hua ; Lin, Yi-Ling | Scientific Reports 11, 8761 | | | |
| 2023 | Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants | Sun, CP ; Chiu, CW; Wu, PY; Tsung, SI; Lee, IJ; Hu, CW; Hsu, MF; Kuo, TJ; Lan, YH; Chen, LY; Ng, HY; Chung, MJ; Liao, HN; Tseng, SC; Lo, CH; Chen, YJ; Liao, CC ; Chang, CS; Liang, JJ; Draczkowski, P; Puri, S; Chang, YC ; Huang, JS; Chen, CC; Kau, JH; Chen, YH ; Liu, WC ; Wu, HC ; Hsu, STD ; Wang, IH ; Tao, MH | Molecular Therapy 31(11), 3322-3336 | | | |
| 2019 | Enterovirus 71 targets the cardiopulmonary system in a robust oral infection mouse model | Chang, CS; Liao, CC ; Liou, AT; Chang, YS; Chang, YT; Tzeng, BH; Chen, CC ; Shih, C | Scientific Reports 9, 11108 | | | |
| 2021 | Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail | Yun-Ju Lai; Chi-Hong Chao; Chun-Che Liao ; Te-An Lee; Jung-Mao Hsu; Wen-Cheng Chou; Jyun Wang; Hsiang-Chi Huang; Shing-Jyh Chang; Yi-Ling Lin ; Chia-Wei Li | AMERICAN JOURNAL OF CANCER RESEARCH 11(5), 2278-2290 | | | |
| 2024 | Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibody | Chang, Y.-H.; Hsu, M.-F.; Chen, W. N.; Wu, M.-H.; Kong, W.L.D.; Lu, M.-Y. J.; Huang, C.-H.; Chang, F.-J.; Chang, L.-Y.; Tsai, H.-Y.; Tung, C.-P.; Yu, J.-H.; Kuo, Y.; Chou, Y.-C. ; Bai, L.-Y.; Chang, Y.-C. ; Chen, A.-Y.; Chen, C.-C.; Chen, Y.-H.; Liao, C.-C. ; Chang, C.-S.; Liang, J.-L.; Lin, Y.-L. ; Angata, T. ; Hsu, S.-T. D ; Lin, K.-I | JCI insight 9(10), e179726 | | | |
| 2023 | Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission | Yang, CF; Liao, CC ; Hsu, HW; Liang, JJ; Chang, CS; Ko, HY; Chang, RH; Tang, WC; Chang, MH; Wang, IH ; Lin, YL | Journal of Biomedical Science 30(1), 87 | | | |
| 2022 | Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan | Chang, Jer-Hwa; Chiou, Jeng-Fong; Hung, Ching-Sheng; Liu, Ming-Che; Chang, Hui-Wen; Hong, Shiao-Ya; Wang, Cheng-Yi; Lin, Yi-Ling ; Hsieh, Yi-Chen; Chung, Chi-Li; Su, Ying-Shih; Hsiao, Shu-Tai Shen; Liu, Doresses; Liang, Jian-Jong; Liao, Chun-Che ; Chang, Chih-Shin; Lai, Kevin Shu-Leung; Chuang, Han-Chuan; Chien, Ko-Ling; Wu, Wei-Ciao; Lee, Yuan-Chii G.; Lin, Sey-En; Shen, Yung-Kang; Hsu, Chiung-Fang; Wang, Jude Chu-Chun; Hsiao, Shih-Hsin | Vaccines 10(2), 312 | | | |
| 2021 | Hyperglycosylated spike of SARS-CoV-2 gamma variant induces breast cancer metastasis | Hsiang-Chi Huang; Liao, Chun-Che ; Shih-Han Wang; I-Jung Lee; Te-An Lee; Jung-Mao Hsu; Chun-Tse Kuo; Jyun Wang; Wan-Chen Hsieh; Shing-Jyh Chang; Shih-Yu Chen ; Mi-Hua Tao ; Yi-Ling Lin ; Yun-Ju Lai; Chia-Wei Li | AMERICAN JOURNAL OF CANCER RESEARCH 11(10), 4994-5005 | | | |
| 2019 | Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model | Liou, A.; Liao, C. ; Chou, S.; Chang, Y.S.; Chang, C.S.; Shih, C. | Journal of Biomedical Science 26(1), 93 | | | |
| 2018 | Immunocompetent and Immunodeficient Mouse Models for Enterovirus 71 Pathogenesis and Therapy. | Shih, C ; Liao, CC ; Chang, YS; Wu, SY; Chang, CS; Liou, AT | Viruses 10(12), 674 | | | |
| 2014 | Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71 | Liao, CC ; Liou, AT; Chang, YS; Wu, SY; Chang, CS; Lee, CK; Kung, JT; Tu, PH; Yu, YY; Lin, CY; Lin, JS; Shih, C | Journal of Virology 88(21), 12485-12499 | | | |
| 2020 | Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives | Yang, Cheng-Wei; Lee, Yue-Zhi; Hsu, Hsing-Yu; Jan, Jia-Tsrong; Lin, Yi-Ling ; Chang, Sui-Yuan; Peng, Tzu-Ting; Yang, Ruey-Bing ; Liang, Jian-Jong; Liao, Chun-Che ; Chao, Tai-Ling; Pang, Yu-Hau; Kao, Han-Chieh; Huang, Wen-Zheng; Lin, Jiunn-Horng; Chang, Chun-Ping; Niu, Guang-Hao; Wu, Szu-Huei; Sytwu, Huey-Kang; Chen, Chiung-Tong; Lee, Shiow-Ju | Frontiers in Pharmacology 11, 606097 | | | |
| 2023 | Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan | Huang, YF; Hsu, FC; Wu, JJ; Lin, YL ; Liu, MT; Yang, CH; Kuo, HS; Chen, YJ; Cheng, CY; Lin, HH; Liao, CC ; Chang, CS; Liang, JJ; Cheng, WY; Huang, JC; Chen, CP; Cheng, SH; Lin, YC; Yang, SH; Chou, YJ | Journal of microbiology, immunology, and infection 56(3), 506-515 | | | |
